ADIM
CSTE icon

Alpha DNA Investment Management’s Caesarstone CSTE Stock Holding History

Alpha DNA Investment Management’s Portfolio CSTE Stock Details CSTE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-377
Closed -$4K – 707
2020
Q4 		$4K Buy
+377
New +$4.3K ﹤0.01% 387

Other funds holding CSTE

Phoenix Financial
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Migdal Insurance & Financial Holdings
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $2.67B AUM 169.09% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Clal Insurance
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
VCM
Venator Capital Management Toronto, Ontario, Canada $48.7M AUM 87.97% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Alpha DNA Investment Management's CSTE Position: Q1 2021 in Review

Alpha DNA Investment Management sold out of Caesarstone (CSTE) in Q1 2021, closing a stake of 377 shares — an estimated $4K sold.

Alpha DNA Investment Management first reported a position in CSTE in Q4 2020 and held it in 1 quarter. The position peaked at $4K in Q4 2020. 119 funds tracked by Wall St. Rank hold CSTE as of Q1 2021.

  • Alpha DNA Investment Management reported no remaining Caesarstone position as of Q1 2021 after selling out during the quarter.
  • Alpha DNA Investment Management sold 377 Caesarstone shares in Q1 2021, an estimated $4K.
  • Alpha DNA Investment Management first reported a position in Caesarstone in Q4 2020 and held it in 1 quarter.
  • Alpha DNA Investment Management's Caesarstone position peaked at $4K in Q4 2020.
  • 119 funds tracked by Wall St. Rank held Caesarstone as of Q1 2021.

Based on Alpha DNA Investment Management's 13F filing for Q1 2021, filed 12 May 2021.